Michael H. Mulroy - 18 Jun 2021 Form 4 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role
Director
Signature
/s/ Grant Harbert, as Attorney-in-Fact
Issuer symbol
LCTX
Transactions as of
18 Jun 2021
Net transactions value
+$54,384
Form type
4
Filing time
21 Jun 2021, 16:15:44 UTC
Next filing
01 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LCTX Common Shares, no par value Options Exercise $54,384 +24,720 +11% $2.20 251,555 18 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LCTX Stock Option (right to buy) Options Exercise $0 -24,720 -100% $0.000000* 0 18 Jun 2021 Common Shares 24,720 $2.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option became exercisable in four equal quarterly installments after the date of grant on July 1, 2016.

Remarks:

Exhibit 24.1 - Substitute Power of Attorney